You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness

Article metrics

Article menu

Download PDFPDF

XML
Clinical trials and drug discovery
The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness

 

Online download statistics by month:

Online download statistics by month: February 2017 to January 2023

AbstractFullPdf
Feb 20170968
Mar 20172177157
Apr 2017125074
May 20171410132
Jun 20179731795
Jul 201733734077
Aug 201723823757
Sep 201737237267
Oct 201724724634
Nov 201726726635
Dec 201753253046
Jan 201862162151
Feb 201847246037
Mar 201841640738
Apr 201837637657
May 201831431349
Jun 201826326241
Jul 201829729757
Aug 201853953945
Sep 201838438461
Oct 201843943969
Nov 201843144043
Dec 201844444445
Jan 2019499491183
Feb 201943743944
Mar 201937937848
Apr 201931832039
May 201932932932
Jun 201930230248
Jul 201929129140
Aug 201923123030
Sep 201922322338
Oct 201927327221
Nov 201925825725
Dec 201925325348
Jan 202028928829
Feb 202038138043
Mar 202026626623
Apr 202017417324
May 202019419237
Jun 202015315123
Jul 202016216234
Aug 202014714419
Sep 202018318019
Oct 202021621130
Nov 202016415815
Dec 202014214016
Jan 202117116929
Feb 202115314737
Mar 202117717536
Apr 202115515332
May 202114514213
Jun 20211021008
Jul 202111211116
Aug 2021717012
Sep 202110410115
Oct 202113513431
Nov 202112011661
Dec 2021828116
Jan 2022787515
Feb 2022808314
Mar 2022767716
Apr 202210410218
May 2022908626
Jun 2022818213
Jul 2022817912
Aug 2022888415
Sep 202211211023
Oct 2022948813
Nov 2022636219
Dec 20227511815
Jan 2023655515
Total15968169662863